SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-019920
Filing Date
2022-08-11
Accepted
2022-08-11 07:10:58
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q arav20220630_10q.htm   iXBRL 10-Q 990684
2 EXHIBIT 31.1 ex_384871.htm EX-31.1 12026
3 EXHIBIT 31.2 ex_384872.htm EX-31.2 12080
4 EXHIBIT 32.1 ex_384873.htm EX-32.1 5435
5 EXHIBIT 32.2 ex_384874.htm EX-32.2 5459
  Complete submission text file 0001437749-22-019920.txt   4898791

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arav-20220630.xsd EX-101.SCH 47113
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20220630_cal.xml EX-101.CAL 27208
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20220630_def.xml EX-101.DEF 310132
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20220630_lab.xml EX-101.LAB 285466
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20220630_pre.xml EX-101.PRE 336797
56 EXTRACTED XBRL INSTANCE DOCUMENT arav20220630_10q_htm.xml XML 704273
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 221153655
SIC: 2834 Pharmaceutical Preparations